Author(s):
1. Sanjay Kalra:
Department of Endocrinology, Bharti Hospital, Karnal, India; University Center for Research & Development, Chandigarh University, Mohali, India
2. Saptarshi Bhattacharya:
Department of Endocrinology, Apollo Hospital,New Delhi,India
3. Hitesh Punyani:
Department of Medicine, Chaitanya CardioDiabetes Centre,New Delhi, India
Abstract:
Diabetes gastroparesis is a common manifestation of autonomic neuropathy in persons with long-standing, uncontrolled diabetes. Most discussion about its management revolves around the mitigation of symptoms. Here, we share tips on choosing the right glucose-lowering medication, based upon predominant symptomatology of gastroparesis. We highlight how insulin preparations, and their timing of administration, can be tailored according to need. We also emphasize the need to choose oral glucose lowering drugs with care.
Page(s):
398-399
Published:
Journal: Journal of Pakistan Medical Association, Volume: 74, Issue: 2, Year: 2024
Keywords:
GLP1RA
,
Personcentred care
,
FI Asp
,
modern sulfonylureas
,
SGLTi
,
tirzepatide
,
URLi
References:
References are not available for this document.
Citations
Citations are not available for this document.